Analysts’ Viewpoint on North America Safety Pen Needles Market Scenario
Rise in prevalence of diabetes and growth hormone deficiency diseases; and increase in geriatric population are driving the North America safety pen needles market. Safety pen needle is a non-invasive portable tool used for the injection of drugs. It offers various advantages over conventional needles. Safety pen needles are intended for professional healthcare users and non-clinical pen users. Technological advancements and integration of alternative technologies are likely to propel the North America safety pen needles market during the forecast period. Emergence of the COVID-19 pandemic has prompted market players to accelerate the production of needles and syringes to support COVID-19 vaccination efforts worldwide.
Safety pen needles are sterile, single-use needles intended for usage with pen injector devices for the injection of drugs. Safety hypodermic needles sometimes cause Needle Stick Injuries (NSIs). Introduction of safety pen needles, with incorporated sharps injury prevention features, reduces the risk of injury and spread of infectious diseases. NSIs are one of the common health hazards in the healthcare setting. According to the World Health Organization, about 3 million of the 35 million healthcare workers worldwide are exposed to blood-borne pathogens annually.
Adoption of hypodermic syringes with safety devices helps reduce cases of NSIs among healthcare workers. Pen needles are often implicated in the risk of sharps injury, as they are used widely by diabetic patients as well as healthcare workers giving subcutaneous injections to patients. Pen needles with automatic protective safety features minimize the risk of exposure to blood-borne infections associated with NSIs such as hepatitis B, hepatitis C, and HIV, without any related adverse events.
Request a sample to get extensive insights into the Safety Pen Needles Market
Prevalence of diabetes is expected to increase exponentially in North America in the near future, due to significant changes in lifestyle and rise in cases of malnutrition and genetic mutations in the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, 10.5% of the U.S. population was suffering from diabetes, which accounted for around 34.2 million people, including 26.9 million people who were diagnosed and 7.3 million people who remained undiagnosed. Additionally, 34.5% of the adult U.S. population is suffering from pre-diabetes, which accounts for 88 million people aged 18 years or older, including 24.2 million people aged 65 years or older. Most of the people in the U.S. with insulin-requiring diabetes, totaling more than 5 million, use pen injector needles in their diabetes management regimen.
The global population is aging rapidly, especially in developed economies such as the U.S. According to the World Health Organization (WHO), the global geriatric population is likely to reach around 2 billion (22% of the global population) by 2050 compared to 900 million in 2015. According to CDC’s 2018 estimates, the incidence rate of diagnosed diabetes was higher among adults aged 45 to 64 years and those aged 65 years and older than in adults aged 18 to 44 years. More than 25% of diabetic patients in the U.S. are aged 65 years and above, as per the American Diabetes Association.
Prevalence of diabetes in pediatric population is gradually increasing in North America. According to the American Diabetes Association, the annual incidence of diagnosed diabetes in the U.S. in people under the age of 20 years was estimated at 18,200 with type 1 diabetes and 5,800 with type 2 diabetes. Thus, rise in prevalence of diabetes among the pediatric and geriatric population is expected to fuel the North America safety pen needles market during the forecast period.
Request a custom report on Safety Pen Needles Market
In terms of needle length, the North America safety pen needles market has been segmented into 4 mm, 5 mm, 6 mm, and 8 mm. The 5 mm segment dominated the market in the region, with around 55% share in 2021. Growth of the segment can be ascribed to the increase in adoption of 5 mm safety pen needles among diabetes patients. However, the usage of these needles is likely to decline in the next few years due to the rise in demand for shorter needles that cause lesser pain and enable easier insulin administration.
Based on therapy, the North America safety pen needles market has been divided into insulin, glucagon-like peptide-1, and growth hormone. The insulin segment held around 75% share of the market in the region in 2021. According to the recent North America safety pen needles market forecast, the trend is projected to continue during 2022 to 2031, due to the rise in prevalence of diabetes in the region. As per the American Diabetes Association, 34.2 million people in the U.S., or 10.5% of the population, had diabetes in 2018. 1.5 million people in the U.S. are diagnosed with diabetes annually.
The U.S. dominated the market for safety pen needles in North America in 2021, owing to the presence of key players in the country such as Becton Dickinson and Company, Montmed Inc., UltiMed, Inc., and Arkray USA, Inc. Additionally, the U.S. offers significant opportunities in safety pen needles devices manufacturing, as developing countries are major buyers of high-quality pen needles devices that are priced economically. Introduction of technologically advanced pen needles devices is anticipated to augment the market in the U.S. during the forecast period.
The North America safety pen needles market report concludes with the company profiles section that includes key information about major players in the market. Key players are focusing on product launches, mergers & acquisitions, partnerships, and collaborations to enhance their safety pen needles market share. Becton, Dickinson and Company, Montmed Inc., UltiMed, Inc., Arkray USA, Inc., McKesson Medical-Surgical Inc., Links Medical Products Inc., and Allison Medical Inc. are prominent players operating in this market.
Key players have been profiled in the North America safety pen needles market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 626.4 Mn |
|
Market Forecast Value in 2031 |
More than US$ 1.17 Bn |
|
Growth Rate (2022–2031) |
6.4% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, the qualitative analysis includes drivers, restraints, opportunities, key trends, and a parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The North America safety pen needles market was valued at US$ 626.4 Mn in 2021
The North America safety pen needles market is projected to reach more than US$ 1.17 Bn by 2031
The North America safety pen needles market grew at a CAGR of 2.7% from 2017 to 2021
The North America safety pen needles market is anticipated to grow at a CAGR of 6.4% from 2022 to 2031
The insulin segment held around 75% share of the North America safety pen needles market in 2021
Becton, Dickinson and Company, Montmed Inc., UltiMed, Inc., Arkray USA, Inc., McKesson Medical-Surgical Inc., Links Medical Products Inc., and Allison Medical Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: North America Safety Pen Needle Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. North America Safety Pen Needle Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Average Pricing Analysis
5.2. Disease Prevalence & Incidence Rate in Region
5.3. Regulatory Scenario of North America Safety Pen Needles Market
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. North America Safety Pen Needle Market Analysis and Forecast, By Needle Length
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Needle Length, 2017-2031
6.3.1. 4 mm
6.3.2. 5 mm
6.3.3. 6 mm
6.3.4. 8 mm
6.4. Market Attractiveness By Needle Length
7. North America Safety Pen Needle Market Analysis and Forecast, By Therapy
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Therapy, 2017-2031
7.3.1. Insulin
7.3.2. Glucagon-like Peptide-1 (GLP-1)
7.3.3. Growth Hormone
7.4. Market Attractiveness By Therapy
8. North America Safety Pen Needle Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By End-user, 2017-2031
8.3.1. Long-term Care Facilities
8.3.2. Acute Care Facilities
8.3.3. Home Care Settings
8.4. Market Attractiveness By End-user
9. North America Safety Pen Needle Market Analysis and Forecast, By Country
9.1. Key Findings
9.2. Market Value Forecast By Country
9.2.1. U.S.
9.2.2. Canada
9.3. Market Attractiveness By Country
10. U.S. Safety Pen Needle Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Needle Length, 2017-2031
10.2.1. 4 mm
10.2.2. 5 mm
10.2.3. 6 mm
10.2.4. 8 mm
10.3. Market Value Forecast By Therapy, 2017-2031
10.3.1. Insulin
10.3.2. Glucagon-like Peptide-1 (GLP-1)
10.3.3. Growth Hormone
10.4. Market Value Forecast By End-user, 2017-2031
10.4.1. Long-term Care Facilities
10.4.2. Acute Care Facilities
10.4.3. Home Care Settings
10.5. Market Value Forecast By Country, 2017-2031
11. Canada Safety Pen Needle Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Needle Length, 2017-2031
11.2.1. 4 mm
11.2.2. 5 mm
11.2.3. 6 mm
11.2.4. 8 mm
11.3. Market Value Forecast By Therapy, 2017-2031
11.3.1. Insulin
11.3.2. Glucagon-like Peptide-1 (GLP-1)
11.3.3. Growth Hormone
11.4. Market Value Forecast By End-user, 2017-2031
11.4.1. Long-term Care Facilities
11.4.2. Acute Care Facilities
11.4.3. Home Care Settings
11.5. Market Value Forecast By Country, 2017-2031
12. Competition Landscape
12.1. Market Player – Competition Matrix (By Tier and Size of companies)
12.2. Market Share Analysis By Company (2021)
12.3. Company Profiles
12.3.1. Becton, Dickinson and Company
12.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.1.2. Product Portfolio
12.3.1.3. Financial Overview
12.3.1.4. SWOT Analysis
12.3.1.5. Strategic Overview
12.3.2. Montmed Inc.
12.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.2.2. Product Portfolio
12.3.2.3. Financial Overview
12.3.2.4. SWOT Analysis
12.3.2.5. Strategic Overview
12.3.3. UltiMed, Inc.
12.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.3.2. Product Portfolio
12.3.3.3. Financial Overview
12.3.3.4. SWOT Analysis
12.3.3.5. Strategic Overview
12.3.4. Arkray USA, Inc.
12.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.4.2. Product Portfolio
12.3.4.3. Financial Overview
12.3.4.4. SWOT Analysis
12.3.4.5. Strategic Overview
12.3.5. McKesson Medical-Surgical Inc.
12.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.5.2. Product Portfolio
12.3.5.3. Financial Overview
12.3.5.4. SWOT Analysis
12.3.5.5. Strategic Overview
12.3.6. Links Medical Products Inc.
12.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.6.2. Product Portfolio
12.3.6.3. Financial Overview
12.3.6.4. SWOT Analysis
12.3.6.5. Strategic Overview
12.3.7. Allison Medical Inc.
12.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.3.7.2. Product Portfolio
12.3.7.3. Financial Overview
12.3.7.4. SWOT Analysis
12.3.7.5. Strategic Overview
List of Tables
Table 01: North America Safety Pen Needles Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 02: North America Safety Pen Needles Market Value (US$ Mn) Forecast, by Needle Length 2017–2031
Table 03: North America Safety Pen Needles Market Value (US$ Mn) Forecast, by Therapy 2017–2031
Table 04: North America Safety Pen Needles Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 05: U.S. Safety Pen Needles Market Value (US$ Mn) Forecast, by Needle Length 2017–2031
Table 06: U.S. Safety Pen Needles Market Value (US$ Mn) Forecast, by Therapy 2017–2031
Table 07: U.S. Safety Pen Needles Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 08: Canada Safety Pen Needles Market Value (US$ Mn) Forecast, by Needle Length 2017–2031
Table 09: Canada Safety Pen Needles Market Value (US$ Mn) Forecast, by Therapy 2017–2031
Table 10: Canada Safety Pen Needles Market Value (US$ Mn) Forecast, by End-user 2017–2031
List of Figures
Figure 01: North America Safety Pen Needles Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: North America Safety Pen Needles Market Value Share, by Needle Length, 2021
Figure 03: North America Safety Pen Needles Market Value Share, by Therapy, 2021
Figure 04: North America Safety Pen Needles Market Value Share, by End-user, 2021
Figure 05: North America Safety Pen Needles Market Value Share, by Needle Length, 2021
Figure 06: North America Safety Pen Needles Market, by Needle Length, 2021 and 2031
Figure 07: North America Safety Pen Needles Market Attractiveness Analysis, by 4 mm, 2021–2031
Figure 08: North America Safety Pen Needles Market Attractiveness Analysis, by 5 mm, 2021–2031
Figure 09: North America Safety Pen Needles Market Attractiveness Analysis, by 6 mm, 2021–2031
Figure 10: North America Safety Pen Needles Market Attractiveness Analysis, by 8 mm, 2021–2031
Figure 11: North America Safety Pen Needles Market, by Therapy, 2021 and 2031
Figure 12: North America Safety Pen Needles Market Attractiveness Analysis, by Insulin, 2021–2031
Figure 13: North America Safety Pen Needles Market Attractiveness Analysis, by Glucagon-like Peptide-1 (GLP-1), 2021–2031
Figure 14: North America Safety Pen Needles Market Attractiveness Analysis, by Growth Hormone, 2021–2031
Figure 15: North America Safety Pen Needles Market Value Share Analysis, by Country, 2021 and 2031
Figure 16: North America Safety Pen Needles Market Attractiveness Analysis, by Country, 2017–2031
Figure 17: U.S. Safety Pen Needles Market Value (US$ Mn) Forecast, 2017–2031
Figure 18: U.S. Safety Pen Needles Market Value Share Analysis, by Needle Length, 2021 and 2031
Figure 19: U.S. Safety Pen Needles Market Attractiveness Analysis, by Therapy, 2021–2031
Figure 20: U.S. Safety Pen Needles Market Value Share Analysis, by End-user, 2021 and 2031
Figure 21: Canada Safety Pen Needles Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: Canada Safety Pen Needles Market Value Share Analysis, by Needle Length, 2021 and 2031
Figure 23: Canada Safety Pen Needles Market Attractiveness Analysis, by Therapy, 2021–2031
Figure 24: Canada Safety Pen Needles Market Value Share Analysis, by End-user, 2021 and 2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Safety Pen Needles Market
